Skip to content
Graphic of a grey and white triangle
Graphic of a grey and white triangle

Commercial Intellectual Property

Allen & Overy’s commercial intellectual property team advises clients on the full range of commercial contracts relating to the exploitation of IP rights.

With the ever-growing focus on innovation, protecting and leveraging IP assets is crucial. A&O’s commercial IP lawyers work closely with our M&A and antitrust colleagues to provide coordinated advice on the full range of IP-rich transactions.

We advise on complex cross-border collaborations, joint ventures and strategic licensing deals involving parties all over the world.

Our experience spans the most complex transactions and includes:

  • Licensing, joint ventures and collaborations
  • Sales and other forms of disposal of IP rights, including warranty protection
  • IP due diligence and verification, including related agreements
  • Antitrust risks in licensing, joint venture and non-compete arrangements, including related to the settlement of patent disputes
  • Procedures and negotiations of arrangements for parties seeking to exit, or in the event of insolvency or bankruptcy of one party
  • Distribution, agency, contract manufacture, supply, sponsorship and other commercial agreements
  • IP-backed asset financing and taking security interests over IP assets, including royalty monetisation agreements

Our experience

Marks & Spencer

Marks & Spencer

on the IP aspects of its GBP750m food delivery joint venture with Ocado, the UK’s leading pure play digital grocer.

Exscientia Limited

Exscientia Limited

on a research collaboration and licence agreement with Roche pursuant to which Exscientia will use its AI drug discovery platform to design pre-clinical drug candidates for Roche.

Colfax Corporation

Colfax Corporation

on the complex division and transfer of an existing trade mark portfolio, including WIPO and other foreign trade marks, in connection with its USD57m acquisition of ČKD Kompresory, based in Prague, Czech Republic, from ČKD Group.



on a licence agreement concerning several of its pharmaceutical cancer products with ONO, for several Asian territories.

News and insights

abstract image data transfer concept

News: 31 January 2023

Allen & Overy advises Standard Chartered in a multibank partnership with DekaBank, LBBW and Comyno building the blockchain platform SWIAT

Allen & Overy advised international bank Standard Chartered on entering into a joint venture with big German banks to fund the blockchain platform SWIAT.

Read more
Sky seen through high rise buildings

Publications: 01 February 2022

Soon there will be legal protection for whistleblowers. What are the employer’s obligations?

The Grand Duchy of Luxembourg has just tabled a bill aimed at transposing the European Directive on whistleblowers. Even if the bill has to go through the entire legislative process, and will most…

Read more
A droplet of liquid failing into pharmaceutical test tubes

Publications: 09 June 2021

A&O hosts webinar on drug formulations in life sciences transactions

On Tuesday 25 May 2021, Allen & Overy IP associate Tine Carmeliet chaired a presentation with IP partner Keren Livneh and IP associate Megan McMellon and M&A associate Zara Sproul on “Drug…

Read more
Colourful shapes

Publications: 12 May 2021

The shape of things to come: the value of registered designs in protecting medtech products

As the digital revolution continues to sweep across healthcare, health tech manufacturers are increasingly aware of the need to protect the visual appearance of their products.

Read more

Recognition of our work

Related content